Binding Database

BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 752K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

21 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID

Data

Article Title

Organization

Hexone glucokinase inhibitor and use thereof

Shandong Xuanzhu Pharma Co.

Glucopyranosyl derivatives and their uses

Sunshine Lake Pharma Co.

USE OF HPK1 INHIBITOR IN TREATMENT OF INTERFERON-RELATED DISEASES

Asclepieion Pharmaceutical

MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (PKMYT1) INHIBITORS AND USES THEREOF

Insilico Medicine IP

Substituted 7-(Pyrimidin-4-yl)Quinolin-4(1H)-One Compounds as Cyclin Dependent Kinase Inhibitors

Beigene

4-(2-PYRAZOLO[3,4-B]PYRIDINE-5-YL)ETHYNYL-2-PYRIDINE DERIVATIVES USEFUL AS GCN2 INHIBITORS

IP2IPO Innovations

GLUTARIMIDE-CONTAINING PAN-KRAS-MUTANT DEGRADER COMPOUNDS AND USES THEREOF

Tiger Biotherapeutics

WRN INHIBITORS

Nimbus Wadjet

ERAP INHIBITORS

Universite De Lille

HETEROARYL CARBOXAMIDE COMPOUND

Astellas Pharma

Conduritol aziridine derivatives and uses thereof

University of Saskatchewan

HYDROXYPYRROLIDINE DERIVATIVE AND MEDICINAL APPLICATION THEREOF

Mitsubishi Tanabe Pharma

Inhibitors of receptor interacting protein kinase I for the treatment of disease

University Of Texas

Inhibitors of DNMT1 as anticancer therapeutic agents

Victoria Link

MTOR inhibitor compounds

Galderma Research & Development

Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents

Novartis

Isoquinoline-steroid conjugates and uses thereof

Aerie Pharmaceuticals

Substituted dihydrobenzofuran glycosidase inhibitors

Asceneuron

Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

Vanderbilt University

Pyridone-sulfone morphinan analogs as opioid receptor ligands

Purdue Pharma

Novel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties.

Amgen